402 related articles for article (PubMed ID: 15008953)
1. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.
Chan SL; Yu VC
Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953
[TBL] [Abstract][Full Text] [Related]
2. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
3. The Bcl-2 family: structures, interactions and targets for drug discovery.
Kvansakul M; Hinds MG
Apoptosis; 2015 Feb; 20(2):136-50. PubMed ID: 25398535
[TBL] [Abstract][Full Text] [Related]
4. Regulation of apoptosis by BH3 domains in a cell-free system.
Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
[TBL] [Abstract][Full Text] [Related]
5. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomics: the evolutionary history of the Bcl-2 family.
Lanave C; Santamaria M; Saccone C
Gene; 2004 May; 333():71-9. PubMed ID: 15177682
[TBL] [Abstract][Full Text] [Related]
8. BH3-only proteins in apoptosis and beyond: an overview.
Lomonosova E; Chinnadurai G
Oncogene; 2008 Dec; 27 Suppl 1(Suppl 1):S2-19. PubMed ID: 19641503
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
11. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
12. Canonical Bcl-2 motifs of the Na+/K+ pump revealed by the BH3 mimetic chelerythrine: early signal transducers of apoptosis?
Lauf PK; Heiny J; Meller J; Lepera MA; Koikov L; Alter GM; Brown TL; Adragna NC
Cell Physiol Biochem; 2013; 31(2-3):257-76. PubMed ID: 23466888
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells.
Bettaieb A; Dubrez-Daloz L; Launay S; Plenchette S; Rébé C; Cathelin S; Solary E
Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):307-18. PubMed ID: 12769775
[TBL] [Abstract][Full Text] [Related]
14. BCL-2 family isoforms in apoptosis and cancer.
Warren CFA; Wong-Brown MW; Bowden NA
Cell Death Dis; 2019 Feb; 10(3):177. PubMed ID: 30792387
[TBL] [Abstract][Full Text] [Related]
15. Mimicking the BH3 domain to kill cancer cells.
Ni Chonghaile T; Letai A
Oncogene; 2008 Dec; 27 Suppl 1(0 1):S149-57. PubMed ID: 19641500
[TBL] [Abstract][Full Text] [Related]
16. Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins.
Lutz RJ
Biochem Soc Trans; 2000 Feb; 28(2):51-6. PubMed ID: 10816098
[TBL] [Abstract][Full Text] [Related]
17. Amphipathic tail-anchoring peptide and Bcl-2 homology domain-3 (BH3) peptides from Bcl-2 family proteins induce apoptosis through different mechanisms.
Ko JK; Choi KH; Peng J; He F; Zhang Z; Weisleder N; Lin J; Ma J
J Biol Chem; 2011 Mar; 286(11):9038-48. PubMed ID: 21189256
[TBL] [Abstract][Full Text] [Related]
18. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
19. Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins.
Lama D; Sankararamakrishnan R
Biochemistry; 2010 Mar; 49(11):2574-84. PubMed ID: 20141168
[TBL] [Abstract][Full Text] [Related]
20. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
